Display options
Cite
Yoshikawa M, Nakasa T, Ishikawa M, et al. Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications. Bone Joint Res. 2017;6(5):277-283doi: 10.1302/2046-3758.65.BJR-2016-0187.R1.
Yoshikawa, M., Nakasa, T., Ishikawa, M., Adachi, N., & Ochi, M. (2017). Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications. Bone & joint research, 6(5), 277-283. https://doi.org/10.1302/2046-3758.65.BJR-2016-0187.R1
Yoshikawa, M, et al. "Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications." Bone & joint research vol. 6,5 (2017): 277-283. doi: https://doi.org/10.1302/2046-3758.65.BJR-2016-0187.R1
Yoshikawa M, Nakasa T, Ishikawa M, Adachi N, Ochi M. Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications. Bone Joint Res. 2017 May;6(5):277-283. doi: 10.1302/2046-3758.65.BJR-2016-0187.R1. PMID: 28473335; PMCID: PMC5457645.
Copy Download .nbib Format: NLM
Share it on

Bone Joint Res. 2017 May;6(5):277-283. doi: 10.1302/2046-3758.65.BJR-2016-0187.R1.

Evaluation of autologous skeletal muscle-derived factors for regenerative medicine applications.

Bone & joint research

M Yoshikawa, T Nakasa, M Ishikawa, N Adachi, M Ochi

Affiliations

  1. Department of Orthopaedic Surgery, Institute of Biomedical & Health Sciences, Hiroshima University, Japan.
  2. Department of Orthopaedic Surgery, Institute of Biomedical & Health Sciences, Hiroshima University, Japan [email protected].

PMID: 28473335 PMCID: PMC5457645 DOI: 10.1302/2046-3758.65.BJR-2016-0187.R1

Abstract

OBJECTIVES: Regenerative medicine is an emerging field aimed at the repair and regeneration of various tissues. To this end, cytokines (CKs), growth factors (GFs), and stem/progenitor cells have been applied in this field. However, obtaining and preparing these candidates requires invasive, costly, and time-consuming procedures. We hypothesised that skeletal muscle could be a favorable candidate tissue for the concept of a point-of-care approach. The purpose of this study was to characterize and confirm the biological potential of skeletal muscle supernatant for use in regenerative medicine.

METHODS: Semitendinosus muscle was used after harvesting tendon from patients who underwent anterior cruciate ligament reconstructions. A total of 500 milligrams of stripped muscle was minced and mixed with 1 mL of saline. The collected supernatant was analysed by enzyme-linked immunosorbent assay (ELISA) and flow cytometry. The biological effects of the supernatant on cell proliferation, osteogenesis, and angiogenesis in vitro were evaluated using human mesenchymal stem cells (hMSCs) and human umbilical cord vein endothelial cells (HUVECs).

RESULTS: The supernatant contained several GFs/CKs, with especially high levels of basic fibroblast growth factor, and CD34+ cells as the stem/progenitor cell fraction. With regard to biological potential, we confirmed that cell proliferation, osteoinduction, and angiogenesis in hMSCs and HUVECs were enhanced by the supernatant.

CONCLUSIONS: The current study demonstrates the potential of a new point-of-care strategy for regenerative medicine using skeletal muscle supernatant. This attractive approach and readily-available material could be a promising option for tissue repair/regeneration in the clinical setting.

© 2017 Nakasa et al.

Keywords: Cytokine; Growth factor; Muscle

Conflict of interest statement

ICMJE COI Statement: None declared.

References

  1. Exp Mol Med. 2011 Nov 30;43(11):622-9 - PubMed
  2. J Bone Joint Surg Br. 2009 Aug;91(8):987-96 - PubMed
  3. Tissue Eng Part C Methods. 2008 Jun;14(2):119-28 - PubMed
  4. Am J Pathol. 2006 Oct;169(4):1440-57 - PubMed
  5. J Bone Joint Surg Am. 2009 Sep;91(9):2094-103 - PubMed
  6. Blood Cells Mol Dis. 2001 Sep-Oct;27(5):924-33 - PubMed
  7. Am J Sports Med. 2006 Nov;34(11):1790-800 - PubMed
  8. J Neural Transm (Vienna). 2009 Aug;116(8):995-1005 - PubMed
  9. Pediatr Obes. 2014 Aug;9(4):249-59 - PubMed
  10. J Rheumatol. 2002 Sep;29(9):1920-30 - PubMed
  11. Nature. 1999 Sep 23;401(6751):390-4 - PubMed
  12. Am J Pathol. 1990 Jun;136(6):1235-46 - PubMed
  13. J Orthop Res. 2008 Feb;26(2):176-83 - PubMed
  14. Am J Sports Med. 2015 May;43(5):1147-56 - PubMed
  15. Gene Ther. 2002 May;9(10):642-7 - PubMed
  16. Tissue Eng Part A. 2015 Oct;21(19-20):2548-58 - PubMed
  17. J Cell Biol. 2000 Sep 4;150(5):1085-100 - PubMed
  18. J Clin Orthop Trauma. 2016 Jul-Sep;7(3):183-6 - PubMed
  19. Acta Anat (Basel). 1992;145(3):265-8 - PubMed
  20. Am J Sports Med. 2015 Jun;43(6):1373-9 - PubMed
  21. Physiol Rev. 2003 Jul;83(3):835-70 - PubMed
  22. Clin Orthop Relat Res. 1990 Mar;(252):64-72 - PubMed
  23. Biomaterials. 1990 Jul;11:38-40 - PubMed
  24. Bone Joint J. 2014 Mar;96-B(3):291-8 - PubMed
  25. J Physiol. 2010 Oct 15;588(Pt 20):3849-50 - PubMed
  26. Anal Biochem. 2004 Jun 1;329(1):77-84 - PubMed
  27. Arthroscopy. 2013 Oct;29(10):1712-21 - PubMed

Publication Types